Author

Shujing Ding

University of Cambridge

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:protein structure· 1

Frequent Co-Authors

Chancievan ThangaratnarajahiD· 1 shared Daniel T.D. JonesiD· 1 shared Edmund R.S. KunjiiD· 1 shared Ian M. FearnleyiD· 1 shared Martin S. KingiD· 1 shared Sotiria TavoulariiD· 1 shared Tom J.J. SchirrisiD· 1 shared Vasiliki MavridouiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Chancievan ThangaratnarajahORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Key features of inhibitor binding to the human mitochondrial pyruvate carrier hetero-dimer

Sotiria Tavoulari, Tom J.J. Schirris, Vasiliki Mavridou, Chancievan Thangaratnarajah, Martin S. King, Daniel T.D. Jones, Shujing Ding, Ian M. Fearnley, Edmund R.S. Kunji

The paper identifies key chemical features of inhibitors binding to the human mitochondrial pyruvate carrier hetero-dimer and discovers new inhibitors with higher potency than existing ones.

Molecular Metabolism · Mar 9, 2022Peer-reviewedMolecular Biology